Guideline on biosimilar medicines
Update: 25 November, 2023
This document describes the regulatory framework for biosimilar medicines in the European Union, including their definition, development and approval procedures, and the safety of biosimilar medicines.
File format: PDF
Size: 1974 KB
MD5 Checksum: 09CCCA663896BD7B9DADC4658EB9D14B
Publication date: 25 November, 2023
Downloads: -
PDF Link: Guideline on biosimilar medicines PDF